Health news
The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems for use on closed surgical incisions to aid in reducing the incidence of…
The safety and efficacy of a shorter 5-day course of antibiotics were found to be comparable to a standard 10-day course in children with uncomplicated community-acquired pneumonia (CAP), according to the findings of a clinical…
Increasingly effective treatments have ensured that survival from most forms of cancer has improved significantly in recent years Mortality rates from cancer fell by 26% in the US from 1991 to 2015, creating an estimated…
Intravenous (IV) antibiotic therapy did not confer a significantly increased benefit compared with oral antibiotics as eradication therapy for pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis, according to results of a…
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for tebipenem HBr (tebipenem pivoxil hydrobromide) for the treatment of adults with complicated urinary tract infections (cUTI), including pyelonephritis, caused…
The US Department of Health and Human Services (HHS) added 8 new substances to the 15th Report on Carcinogens, bringing the total list to 256 substances. The 8 newly reviewed substances include the following: Helicobacter…
The cellphones of healthcare workers were found to often be contaminated with several types of bacterial pathogens, according to results of a study published in Infectious Diseases Now. Researchers collected samples from cellphones received from…
Xenleta® (lefamulin) is now available in a 10-count oral pack (or “X” pack) for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates),…
In health care settings where toilets are shared, toilet droplets generated during urination may be a hidden source of carbapenem-resistant Klebsiella pneumoniae (CR-KP) transmission. In addition, the application of a novel foam layer into a…
Treatment with investigational, microbiota-based, live biotherapeutic RBX2660 reduced recurrent Clostridioides difficile infection (rCDI) in patients with rCDI and comorbid conditions, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021